ArticleCommunications medicine2023

Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinoma.

Masami Yamauchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.